| Literature DB >> 33313287 |
Weiyi Lai1, Xiaohang Wu1, Dongni Wang1, Zhenzhen Liu1, Duoru Lin1, Lanqin Zhao1, Weirong Chen1, Haotian Lin1,2, Yizhi Liu1.
Abstract
BACKGROUND: Although influencing the severity of postoperative intraocular inflammation of congenital cataract, the developmental characteristics of cytokine profile in the aqueous humor during childhood had not been described. And its relationship with the inflammatory response after intraocular surgery remained unsolved.Entities:
Keywords: Aqueous humor; congenital cataract (CC); cytokines; pediatrics
Year: 2020 PMID: 33313287 PMCID: PMC7729307 DOI: 10.21037/atm-19-2377
Source DB: PubMed Journal: Ann Transl Med ISSN: 2305-5839
EPCO grading scale
| Grade | Description |
|---|---|
| 1 | Minimum wrinkling of capsule with a fine layer of LECs |
| 2 | Mild honeycomb PCO; thicker layer of LECs with dense fibrosis |
| 3 | Classic elschnig pearls; very thick layer of LECs |
| 4 | Severe opacity with a darkening effect |
EPCO, evaluation of posterior capsule opacification; LECs, lens epithelial cells; PCO, posterior capsule opacification.
Patient baseline characteristics
| Variable | Congenital cataract | Age-related cataract |
|---|---|---|
| Sample size | 65 | 13 |
| Sex ratio (male%) | 58.46% (38/65) | 46.15% (6/13) |
| Ratio of bilaterality | 72.31% (47/65) | 100.00% (13/13) |
| Age when sampled (mean ± SD, years) | 3.89±2.34 | 70.46±3.93 |
| Major surgical procedures | I/A + IOL + PCCC + A-Vit† (84.62%, 55/65) | Phaco + IOL‡ (100.00%, 13/13) |
Age distribution of the congenital cataract group: 7 patients (≤1 years old); 8 patients (1–2 years old); 10 patients (2–3 years old); 13 patients (3–4 years old); 11 patients (4–5 years old); 5 patients (5–6 years old); 11 patients (>6 years old). †, I/A + IOL + PCCC + A-Vit = lens aspiration with IOL implantation, posterior continuous curvilinear capsulorhexis and anterior vitrectomy; ‡, Phaco + IOL = cataract phacoemulsification and intraocular lens implantation.
Comparison of cytokine microenvironments between adults and children
| Factors | Congenital cataract (n=65) | Age-related cataract (n=13) | P (Mann-Whitney U test) | |||||
|---|---|---|---|---|---|---|---|---|
| Mean SD (pg/mL) | Median, 25th–75th interquartile range (pg/mL) | P (Shapiro-Wilk test) | Mean SD (pg/mL) | Median, 25th–75th interquartile range (pg/mL) | P (Shapiro-Wilk test) | |||
| EGF | 3.19±0.95 | 3.01 (2.68–3.39) | <0.001 | 3.39±0.41 | 3.39 (3.23–3.69) | 0.051 | 0.013* | |
| FGF-2 | 15.48±30.40 | 6.47 (1.28–19.57) | <0.001 | 17.96±23.33 | 11.56 (6.47–16.95) | <0.001 | 0.175 | |
| G-CSF | 3.59±2.62 | 2.77 (2.01–4.82) | <0.001 | 1.74±0.25 | 1.78 (1.57–1.86) | 0.736 | <0.001** | |
| GM-CSF | 1.26±0.28 | 1.22 (1.07–1.40) | <0.001 | 1.36±0.13 | 1.40 (1.24–1.48) | 0.733 | 0.020* | |
| IFN-α2 | 7.25±7.23 | 3.92 (2.65–8.94) | <0.001 | 1.92±0.25 | 1.93 (1.75–2.12) | 0.421 | <0.001** | |
| IL-10 | 1.28±0.48 | 1.20 (1.09–1.36) | <0.001 | 1.41±0.28 | 1.36 (1.24–1.51) | 0.001 | 0.013* | |
| IL-12p40 | 2.29±1.56 | 1.84 (1.44–2.27) | <0.001 | 1.77±0.23 | 1.69 (1.55–1.92) | 0.078 | 0.605 | |
| IL-12p70 | 1.42±0.48 | 1.31 (1.13–1.58) | <0.001 | 1.53±0.10 | 1.50 (1.46–1.58) | 0.096 | 0.041* | |
| IL-13 | 1.48±0.51 | 1.37 (1.24–1.59) | <0.001 | 1.37±0.21 | 1.37 (1.23–1.46) | 0.265 | 0.668 | |
| IL-1RA | 10.76±30.85 | 1.85 (1.02–5.91) | <0.001 | 1.44±0.46 | 1.37 (1.09–1.83) | 0.806 | 0.091 | |
| IL-1α | 1.21±0.44 | 1.12 (0.98–1.29) | <0.001 | 1.00±0.12 | 0.98 (0.92–1.09) | 0.342 | 0.016* | |
| IL-1β | 0.66±0.13 | 0.63 (0.55–0.73) | <0.001 | 0.70±0.07 | 0.73 (0.63–0.76) | 0.268 | 0.064 | |
| IL-2 | 1.47±0.29 | 1.44 (1.33–1.60) | <0.001 | 1.69±0.14 | 1.63 (1.56–1.82) | 0.275 | <0.001** | |
| IL-3 | 0.51±0.58 | 0.16 (0.01–1.05) | <0.001 | 1.02±0.10 | 1.00 (0.96–1.10) | 0.941 | 0.012* | |
| IL-4 | 2.39±1.38 | 1.97 (1.65–2.80) | <0.001 | 3.40±0.77 | 3.39 (2.80–4.10) | 0.935 | <0.001** | |
| IL-5 | 0.59±0.98 | 0.43 (0.36–0.57) | <0.001 | 0.58±0.04 | 0.58 (0.55–0.62) | 0.441 | 0.002** | |
| IL-6 | 4.91±23.11 | 1.64 (1.39–2.13) | <0.001 | 3.70±2.58 | 2.62 (1.99–4.90) | 0.002 | <0.001** | |
| IL-7 | 3.27±3.17 | 2.11 (1.77–3.60) | <0.001 | 1.84±0.23 | 1.77 (1.67–2.01) | 0.165 | 0.031* | |
| IL-8 | 4.76±9.29 | 2.19 (1.55–3.59) | <0.001 | 4.23±1.27 | 4.18 (3.27–4.88) | 0.255 | 0.004** | |
| MCP-1 | 803.28±439.20 | 645.01 (534.19–989.08) | <0.001 | 927.61±399.44 | 872.22 (621.58–1,028.04) | 0.007 | 0.064 | |
| TNFα | 0.95±0.28 | 0.89 (0.76–1.06) | <0.001 | 1.06±0.08 | 1.05 (1.02–1.12) | 0.341 | 0.011* | |
| IFN-γ | 1.30±0.26 | 1.24 (1.15–1.43) | <0.001 | 1.30±0.09 | 1.26 (1.24–1.37) | 0.792 | 0.455 | |
*, correlation is significant at the 0.05 level (2-tailed); **, correlation is significant at the 0.01 level (two-tailed). SD, standard deviation; EGF, epidermal growth factor; FGF, fibroblast growth factor; G-CSF, granulocyte colony stimulating factor; GM-CSF, granulocyte-macrophage colony stimulating factor; IFN, interferon; IL, interleukin; MCP-1, monocyte chemotactic protein-1; TNF, tumor necrosis factor.
Figure 1Four age-correlated cytokines. (A) EGF; (B) IL-3; (C) IL-8; (D) MCP-1. EGF, epidermal growth factor; MCP-1, monocyte chemotactic protein-1; IL, interleukin.
Univariate and multivariate analyses of four age-correlated cytokines
| Cytokine | Univariate analysis (spearman correlation) | Multivariate analysis (LASSO and multivariate linear regression) | ||||||
|---|---|---|---|---|---|---|---|---|
| Predictor | ρ | P (two-tailed) | Standardized coefficient (β) | P | Adjusted R square | Significance of regression in ANOVA | ||
| EGF | FGF-2 | 0.337 | 0.006 | Out | – | 0.752 | <0.001 | |
| GM-CSF | 0.451 | <0.001 | 0.280 | 0.013 | ||||
| IL-10 | 0.326 | 0.008 | Out | – | ||||
| IL-12p70 | 0.501 | <0.001 | Out | – | ||||
| IL-13 | 0.316 | 0.010 | Out | – | ||||
| IL-1β | 0.483 | <0.001 | Out | – | ||||
| IL-3 | 0.584 | <0.001 | Out | – | ||||
| IL-4 | 0.499 | <0.001 | 0.429 | 0.001 | ||||
| IL-5 | 0.514 | <0.001 | −0.146 | 0.039 | ||||
| IL-6 | 0.300 | 0.015 | Out | – | ||||
| TNF-α | 0.459 | <0.001 | 0.275 | 0.013 | ||||
| Age | 0.281 | 0.024 | Out | – | ||||
| IL-3 | EGF | 0.584 | <0.001 | Out | – | 0.714 | <0.001 | |
| FGF-2 | 0.681 | <0.001 | Out | – | ||||
| GM-CSF | 0.536 | <0.001 | Out | – | ||||
| IFN-α2 | −0.282 | 0.023 | Out | – | ||||
| IL-10 | 0.560 | <0.001 | Out | – | ||||
| IL-12p70 | 0.713 | <0.001 | Out | – | ||||
| IL-13 | 0.313 | 0.011 | Out | – | ||||
| IL-1α | −0.298 | 0.016 | Out | – | ||||
| IL-1β | 0.677 | <0.001 | 0.312 | 0.002 | ||||
| IL-4 | 0.851 | <0.001 | 0.594 | <0.001 | ||||
| IL-5 | 0.712 | <0.001 | Out | – | ||||
| MCP-1 | −0.284 | 0.022 | Out | – | ||||
| TNF-α | 0.719 | <0.001 | Out | – | ||||
| Age | 0.294 | 0.017 | Out | – | ||||
| IL-8 | IL-10 | 0.329 | 0.007 | Out | – | 0.500 | <0.001 | |
| IL-13 | 0.255 | 0.041 | Out | – | ||||
| IL-6 | 0.577 | <0.001 | 0.273 | 0.006 | ||||
| MCP-1 | 0.794 | <0.001 | 0.564 | <0.001 | ||||
| Age | −0.460 | <0.001 | Out | – | ||||
| MCP-1 | IL-1α | 0.283 | 0.022 | Out | – | 0.542 | <0.001 | |
| IL-3 | −0.284 | 0.022 | Out | – | ||||
| IL-4 | −0.288 | 0.020 | Out | – | ||||
| IL-6 | 0.560 | <0.001 | Out | – | ||||
| IL-8 | 0.794 | <0.001 | 0.574 | <0.001 | ||||
| Age | −0.494 | <0.001 | −0.337 | <0.001 | ||||
LASSO, least absolute shrinkage and selection operator; EGF, epidermal growth factor; FGF, fibroblast growth factor; GM-CSF, granulocyte-macrophage colony stimulating factor; IL, interleukin; TNF, tumor necrosis factor; IFN, interferon; MCP-1, monocyte chemotactic protein-1.
Univariate and multivariate analyses of the inflammatory proliferative response after surgery
| Dependent variable | Univariate analysis (spearman correlation) | Multivariate analysis (LASSO and multivariate linear regression) | ||||||
|---|---|---|---|---|---|---|---|---|
| Predictor | ρ | P (two-tailed) | Standardized coefficient (β) | P | Adjusted R square | Significance of regression in ANOVA | ||
| EPCO (3 months after surgery, n=30) | EGF | −0.552 | 0.002 | Out | – | 0.213 | 0.006 | |
| FGF-2 | −0.533 | 0.002 | Out | – | ||||
| IL-12p70 | −0.464 | 0.010 | Out | – | ||||
| IL-1β | −0.522 | 0.003 | Out | – | ||||
| IL-3 | −0.625 | <0.001 | −0.490 | 0.006 | ||||
| IL-4 | −0.546 | 0.002 | Out | – | ||||
| IL-5 | −0.522 | 0.003 | Out | – | ||||
| MCP-1 | 0.368 | 0.046 | Out | – | ||||
| TNF-α | −0.520 | 0.003 | Out | – | ||||
| EPCO (6 months after surgery, n=26) | IL-1β | −0.423 | 0.031 | Out | – | 0.320 | 0.002 | |
| Age | −0.497 | 0.010 | −0.589 | 0.002 | ||||
| EPCO (1 year after surgery, n=22) | EGF | −0.450 | 0.035 | −0.415 | 0.044 | 0.238 | 0.029 | |
| IL-3 | −0.428 | 0.047 | Out | – | ||||
| Age | −0.472 | 0.027 | −0.318 | 0.115 | ||||
LASSO, least absolute shrinkage and selection operator; EPCO, evaluation of posterior capsule opacification; EGF, epidermal growth factor; FGF, fibroblast growth factor; IL, interleukin; MCP-1, monocyte chemotactic protein-1; TNF, tumor necrosis factor.